J
John T. Wei
Researcher at University of Michigan
Publications - 395
Citations - 32685
John T. Wei is an academic researcher from University of Michigan. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 82, co-authored 385 publications receiving 30140 citations. Previous affiliations of John T. Wei include Johns Hopkins University & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
175: Regionalization of Partial and Radical Nephrectomy to Specific Medical Centers
Journal ArticleDOI
Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index.
Takahiro Osawa,John T. Wei,Takashige Abe,Michitaka Honda,Shuhei Yamada,Jun Furumido,Hiroshi Kikuchi,Ryuji Matsumoto,Kazushi Hirakawa,Yasuyuki Sato,Yoshihiro Sasaki,Toru Harabayashi,Norikata Takada,Keita Minami,Hiroshi Tanaka,Ken Morita,Akira Kashiwagi,Naoto Miyajima,Tomoshige Akino,Sachiyo Murai,Yoichi M. Ito,Shunichi Fukuhara,Shunichi Fukuhara,Katsuhiko Ogasawara,Nobuo Shinohara +24 more
TL;DR: A Japanese version of the Bladder Cancer Index (BCI) is validated as a tool for measuring health-related quality of life (HRQOL) in bladder cancer patients treated with various surgical procedures and could be used for cross-cultural assessments of HRQOL in bladdercancer patients.
Journal ArticleDOI
Pii-lba2 validation of a novel non-invasive urine exosome gene expression assay to predict high-grade prostate cancer in patients undergoing initial biopsy with an equivocal psa.
James M. McKiernan,Michael J. Donovan,Vince O'Neill,Stefan Bentink,Mikkel Noerholm,Susan Belzer,Johan Skog,Alan W. Partin,Gerald L. Andriole,Gordon D. Brown,James S. Cochran,John T. Wei,Ian M. Thompson,Peter R. Carroll +13 more
TL;DR: Validation of a Novel Non-Invasive Urine Exosome Gene Expression assay to predict High-grade prostate cancer in patients undergoing initial biopsy with an equivocal PSA is validated.
Journal ArticleDOI
Introduction of laser technology and procedure use for benign prostatic hyperplasia: data from Florida.
TL;DR: Adoption of laser technology is associated with rising rates of surgical intervention for benign prostatic hyperplasia, and this trend appears to be induced by the introduction of laser surgery.